EdgarLookup

Ensysce Biosciences, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Financials Insiders
Insider Title Type Shares Price Value Date
GOWER BOB G Purchase 90,287 $0.49 $44,241 Mar 2, 2023
GOWER BOB G Purchase 270,000 $0.48 $129,600 Feb 28, 2023
GOWER BOB G Purchase 357,143 $1.40 $500,000 Dec 9, 2022
Kirkpatrick Lynn Chief Executive Officer Purchase 70,000 $0.49 $34,300 May 26, 2022
Humphrey David Carl Chief Financial Officer Award / Grant 50,000 Jun 30, 2021
Chang William H Award / Grant 2,242,189 Jun 30, 2021
GOWER BOB G Award / Grant 7,919,026 Jun 30, 2021
Kirkpatrick Lynn Chief Executive Officer Award / Grant 284,851 Jun 30, 2021
MORGAN STANLEY Sale 776,290 Jun 19, 2020
Matthews Lane Capital Partners LLC Other 171,832 Jan 15, 2018
Carrera Eric Senior Vice President Other 8,330 Jan 15, 2018
Peng George Chief Financial Officer Other 13,251 Jan 15, 2018
WEIL A LORNE Executive Chairman Other 40,645 Jan 15, 2018
Peng George Chief Financial Officer Other 733 Dec 5, 2017
Carrera Eric Senior Vice President Other 1,465 Dec 5, 2017
HG Vora Capital Management, LLC Other 718,750 Dec 5, 2017
WEIL A LORNE Executive Chairman Other 187,166 Dec 5, 2017
Silvers Daniel B. Chief Executive Officer Other 359,869 Dec 5, 2017
HG Vora Capital Management, LLC Other 375,000 Dec 1, 2017